Advertisement
Screener

Moleculin Biotech, Inc. (MBRX) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

Moleculin Biotech, Inc. Capital Expenditures

Moleculin Biotech, Inc. (MBRX) reported Capital Expenditures of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-18

  • Moleculin Biotech, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00.
  • Moleculin Biotech, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00.
  • Moleculin Biotech, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
  • Moleculin Biotech, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $0.00.
  • Moleculin Biotech, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • Moleculin Biotech, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $13.00K, a 89.52% decline from fiscal 2023.
  • Moleculin Biotech, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $124.00K, a 85.07% increase from fiscal 2022.
  • Moleculin Biotech, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $67.00K, a 252.63% increase from fiscal 2021.
Period endPayments to Acquire Property, Plant, and Equipment 2 monthPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 5 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 9 month as first filedPayments to Acquire Property, Plant, and Equipment 12 monthPayments to Acquire Property, Plant, and Equipment 12 month as first filed
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$0.00
derived: sum of 2 quarters · filed 2026-03-18
$0.00
derived: sum of 3 quarters · filed 2026-03-18
$0.00
10-K · filed 2026-03-18
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$0.00
derived: sum of 2 quarters · filed 2025-11-13
$0.00
10-Q · filed 2025-11-13
$0.00
derived: sum of 4 quarters · filed 2026-03-18
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
$0.00
10-Q · filed 2025-08-12
$0.00
derived: sum of 3 quarters · filed 2026-03-18
$0.00
derived: sum of 4 quarters · filed 2026-03-18
2025-03-31$0.00
10-Q · filed 2025-05-13
$0.00
derived: sum of 2 quarters · filed 2026-03-18
$0.00
derived: sum of 3 quarters · filed 2026-03-18
$13.00K
derived: sum of 4 quarters · filed 2026-03-18
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$0.00
derived: sum of 2 quarters · filed 2026-03-18
$13.00K
derived: sum of 3 quarters · filed 2026-03-18
$13.00K
10-K · filed 2026-03-18
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$13.00K
derived: sum of 2 quarters · filed 2025-11-13
$13.00K
10-Q · filed 2025-11-13
$94.00K
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$13.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
$13.00K
10-Q · filed 2025-08-12
$94.00K
derived: sum of 3 quarters · filed 2025-08-12
$122.00K
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$0.00
10-Q · filed 2025-05-13
$81.00K
derived: sum of 2 quarters · filed 2025-05-13
$109.00K
derived: sum of 3 quarters · filed 2025-05-13
$124.00K
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$81.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21
$109.00K
derived: sum of 2 quarters · filed 2025-03-21
$124.00K
derived: sum of 3 quarters · filed 2025-03-21
$124.00K
10-K · filed 2025-03-21
2023-09-30$28.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$43.00K
derived: sum of 2 quarters · filed 2024-11-08
$43.00K
10-Q · filed 2024-11-08
$43.00K
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30$15.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$15.00K
10-Q · filed 2024-08-13
$15.00K
derived: sum of 3 quarters · filed 2024-08-13
$15.00K
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$0.00
10-Q · filed 2023-05-10
$0.00
derived: sum of 2 quarters · filed 2024-03-22
$0.00
derived: sum of 3 quarters · filed 2024-03-22
$61.00K
derived: sum of 4 quarters · filed 2024-03-22
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22
$0.00
derived: sum of 2 quarters · filed 2024-03-22
$61.00K
derived: sum of 3 quarters · filed 2024-03-22
$67.00K
10-K · filed 2024-03-22
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$61.00K
derived: sum of 2 quarters · filed 2023-11-13
$67.00K
10-Q · filed 2023-11-13
$86.00K
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$61.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$67.00K
10-Q · filed 2023-08-10
$86.00K
derived: sum of 3 quarters · filed 2023-08-10
$86.00K
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$6.00K
10-Q · filed 2023-05-10
$25.00K
derived: sum of 2 quarters · filed 2023-05-10
$25.00K
derived: sum of 3 quarters · filed 2023-05-10
$25.00K
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$19.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22
$19.00K
derived: sum of 2 quarters · filed 2023-03-22
$19.00K
derived: sum of 3 quarters · filed 2023-03-22
$19.00K
10-K · filed 2023-03-22
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$0.00
derived: sum of 2 quarters · filed 2022-11-10
$0.00
10-Q · filed 2022-11-10
$16.00K
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$0.00
10-Q · filed 2022-08-12
$16.00K
derived: sum of 3 quarters · filed 2022-08-12
$356.00K
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$0.00
10-Q · filed 2022-05-11
$16.00K
derived: sum of 2 quarters · filed 2022-05-11
$356.00K
derived: sum of 3 quarters · filed 2022-05-11
$374.00K
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31$16.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24
$356.00K
derived: sum of 2 quarters · filed 2022-03-24
$374.00K
derived: sum of 3 quarters · filed 2022-03-24
$376.00K
10-K · filed 2022-03-24
2020-09-30$340.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$358.00K
derived: sum of 2 quarters · filed 2021-11-10
$360.00K
10-Q · filed 2021-11-10
$370.00K
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$18.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
$20.00K
10-Q · filed 2021-08-11
$30.00K
derived: sum of 3 quarters · filed 2021-08-11
$38.00K
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$2.00K
10-Q · filed 2021-05-12
$12.00K
derived: sum of 2 quarters · filed 2021-05-12
$20.00K
derived: sum of 3 quarters · filed 2021-05-12
$39.00K
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$10.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24
$18.00K
derived: sum of 2 quarters · filed 2021-03-24
$37.00K
derived: sum of 3 quarters · filed 2021-03-24
$52.00K
10-K · filed 2021-03-24
2019-09-30$8.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$27.00K
derived: sum of 2 quarters · filed 2020-11-12
$42.00K
10-Q · filed 2020-11-12
$156.00K
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$19.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
$34.00K
10-Q · filed 2020-08-12
$148.00K
derived: sum of 3 quarters · filed 2020-08-12
$443.00K
derived: sum of 4 quarters · filed 2020-08-12
2019-03-31$15.00K
10-Q · filed 2020-05-11
$129.00K
derived: sum of 2 quarters · filed 2020-05-11
$424.00K
derived: sum of 3 quarters · filed 2020-05-11
$424.00K
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$114.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19
$409.00K
derived: sum of 2 quarters · filed 2020-03-19
$409.00K
derived: sum of 3 quarters · filed 2020-03-19
$417.00K
10-K · filed 2020-03-19
2018-09-30$295.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$295.00K
derived: sum of 2 quarters · filed 2019-11-12
$303.00K
10-Q · filed 2019-11-12
$319.00K
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-16
$8.00K
10-Q · filed 2019-08-16
$24.00K
derived: sum of 3 quarters · filed 2019-08-16
$32.00K
derived: sum of 4 quarters · filed 2019-08-16
2018-03-31$8.00K
10-Q · filed 2019-05-13
$24.00K
derived: sum of 2 quarters · filed 2019-05-13
$32.00K
derived: sum of 3 quarters · filed 2019-05-13
$36.00K
derived: sum of 4 quarters · filed 2019-05-13
2017-12-31$16.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21
$24.00K
derived: sum of 2 quarters · filed 2019-02-21
$28.00K
derived: sum of 3 quarters · filed 2019-02-21
$28.00K
10-K · filed 2019-02-21
2017-09-30$8.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
$12.00K
derived: sum of 2 quarters · filed 2018-11-13
$12.00K
10-Q · filed 2018-11-13
$23.00K
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30$4.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10
$4.00K
10-Q · filed 2018-08-10
$15.00K
derived: sum of 3 quarters · filed 2018-08-10
$25.00K
derived: sum of 4 quarters · filed 2018-08-10
2017-03-31$0.00
10-Q · filed 2018-05-14
$11.00K
derived: sum of 2 quarters · filed 2018-05-14
$21.00K
derived: sum of 3 quarters · filed 2018-05-14
2016-12-31$11.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28
$21.00K
derived: sum of 2 quarters · filed 2018-03-28
$21.00K
10-K · filed 2018-03-28
$21.47K
10-K · filed 2017-04-03
2016-09-30$10.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13
$10.00K
10-Q · filed 2017-11-13
$10.15K
10-Q · filed 2016-11-21
2016-06-30$0.00
10-Q · filed 2017-08-11
2015-12-31$0.00
10-K · filed 2017-04-03
2015-09-30$0.00
10-Q · filed 2016-11-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
MetaVia Inc. (MTVA)United States$0.011B-0.65
KALA BIO, Inc. (KALA)United States$0.011B-3.33
Theriva Biologics, Inc. (TOVX)United States$0.011B
Dare Bioscience, Inc. (DARE)United States$0.011B
Azitra, Inc. (AZTR)United States$0.010B-0.81
Medicus Pharma Ltd. (MDCX)$0.010B
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92